Topics:

Pain

Pain

The results of several recent studies on both drug classes may come as a surprise. Will they change the way you prescribe either or both for pain?

Polycystic ovary syndrome, “dermatoses of pregnancy,” systemic sclerosis, subacute cutaneous lupus erythematosus, gallbladder agenesis, sarcoidosis—a close look at medical problems seen frequently in women.

The FDA has approved an abuse-resistant version of oxycodone, Targiniq ER.

The answer to this question has long been considered to be, "yes" and for what seem to be logical reasons related to the nature of chronic pain. But, where's the science to support the belief?

Necrobiosis

Put yourself to the test: This week’s quiz questions you about skin disease, diabetes, sarcoidosis, atrial flutter, and pain medications.

The study showed no long-term benefit of glucocorticoid injections for spinal stenosis, calling some preoperative insurance requirements into question.

Plenty for rheumatologists in NEJM this week: A deadly vasculitis, Phase 2 results for a new psoriatic arthritis drug, and a solution for constipation with opioids.

Pages

Subscribe to Pain on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.